Plan Now or Fail Later: Why raw materials matter

Register Free: https://www.biopharminternational.com/bp_w/raw_materials

Event Overview:

Accelerating the development of mRNA vaccines and therapeutics requires the selection and use of raw materials designed to meet critical process, scale, quality, and regulatory needs. Choosing appropriate materials saves time and money. This presentation reviews several examples of how raw material selection either accelerated or stalled regulatory approvals. This presentation will cover:

• Criteria for selecting appropriate materials for developing and manufacturing mRNA therapeutics and vaccines
• How to select the best raw materials for each stage of development and manufacture an mRNA vaccine or therapeutic
• Case studies of the raw material decisions made by various companies and how those decisions impacted their drug development project

Key Learning Objectives:

• Understand some of the key requirements for selecting raw materials for mRNA therapeutics and vaccine development and manufacturing
• Learn how to match the appropriate material with the process of drug development and manufacturing
• Review examples of companies who made good or bad decisions in raw materials and how those choices impacted their projects

Who Should Attend:

• Process Development Scientists, Engineers and Managers
• Manufacturing Engineers and Managers
• Principal Investigators
• Senior Research Associates
• Bioprocess Engineers
• Strategic Sourcing Managers

Speakers

Darwin Asa, PhD
Global Market Development Manager
Thermo Fisher Scientific

Dr. Darwin Asa received his BS in Honors Biology from the University of Michigan-Flint and PhD in Biochemistry from the University of Illinois. He did post-doctoral work in both biotech and pharmaceutical companies. Over the course of his almost 30-year career, he has held a variety of research, product development and marketing positions. Dr. Asa has worked in a wide range of research fields including Cell and Molecular Biology, Genomics, Proteomics, and Analytical Chemistry He has also managed several products and technologies used in the process and analytical development of pharmaceuticals. His experience also includes work on a number of products and technologies in Clinical Diagnostics products in Oncology, Clinical Chemistry, and Microbiology. He recently joined Thermo Fisher Scientific and is currently the Global Market Development Manager for Nucleic Acid Therapeutics, responsible for many of the materials used in development and manufacturing of oligonucleotide therapeutics and mRNA vaccines.

Register Free: https://www.biopharminternational.com/bp_w/raw_materials